Markel Group (NYSE:MKL) Now Covered by Analysts at Brean Capital

Brean Capital began coverage on shares of Markel Group (NYSE:MKL) in a report issued on Tuesday. The brokerage set a “neutral” rating and a $2,100.00 price target on the insurance provider’s stock. Brean Capital’s target price indicates a potential upside of 10.87% from the company’s previous close.

Other equities analysts also recently issued reports about the company. Zacks Research downgraded Markel Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, January 19th. Wall Street Zen upgraded Markel Group from a “hold” rating to a “buy” rating in a research report on Saturday, March 14th. Truist Financial upped their price objective on Markel Group from $2,000.00 to $2,100.00 and gave the stock a “hold” rating in a research note on Friday, February 6th. Finally, Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Markel Group in a research report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $2,100.00.

Markel Group Stock Up 0.3%

Shares of MKL stock traded up $4.94 on Tuesday, hitting $1,894.10. The stock had a trading volume of 1,417 shares, compared to its average volume of 48,216. The stock’s 50 day moving average is $2,030.73 and its 200-day moving average is $2,022.87. The firm has a market capitalization of $23.83 billion, a price-to-earnings ratio of 11.13 and a beta of 0.77. Markel Group has a 52-week low of $1,621.89 and a 52-week high of $2,207.59. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.63 and a current ratio of 0.63.

Insiders Place Their Bets

In other news, CEO Simon Wilson sold 100 shares of the stock in a transaction on Thursday, February 26th. The stock was sold at an average price of $2,079.48, for a total value of $207,948.00. Following the completion of the transaction, the chief executive officer owned 2,397 shares of the company’s stock, valued at approximately $4,984,513.56. This represents a 4.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.66% of the stock is owned by insiders.

Hedge Funds Weigh In On Markel Group

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Diversify Advisory Services LLC boosted its holdings in Markel Group by 4.5% during the fourth quarter. Diversify Advisory Services LLC now owns 116 shares of the insurance provider’s stock worth $239,000 after buying an additional 5 shares in the last quarter. Keybank National Association OH increased its holdings in shares of Markel Group by 0.7% in the fourth quarter. Keybank National Association OH now owns 765 shares of the insurance provider’s stock valued at $1,644,000 after buying an additional 5 shares in the last quarter. Wellington Shields & Co. LLC lifted its position in shares of Markel Group by 3.2% during the 4th quarter. Wellington Shields & Co. LLC now owns 160 shares of the insurance provider’s stock valued at $344,000 after acquiring an additional 5 shares during the last quarter. Root Financial Partners LLC boosted its stake in shares of Markel Group by 13.9% during the 4th quarter. Root Financial Partners LLC now owns 41 shares of the insurance provider’s stock worth $88,000 after acquiring an additional 5 shares in the last quarter. Finally, Moneta Group Investment Advisors LLC grew its holdings in shares of Markel Group by 4.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 118 shares of the insurance provider’s stock worth $254,000 after acquiring an additional 5 shares during the last quarter. Institutional investors own 77.12% of the company’s stock.

Markel Group Company Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.